InvestorsHub - NYSE, NASDAQ, AMEX, OTCBB, Pink Sheet Stock Message Boards, Stock Charts, Stock Quotes, Level II and Market News

Ticker	Name	Price	Change	Change %	Volume	Posts
ASPS	Altisource Portfolio Solutions SA	0.8233	0.5548	206.59%	469,509	110
ICCT	iCoreConnect Inc	4.20	2.13	102.90%	176,628,084	3,659
PTIX	Protagenic Therapeutics Inc	0.4168	0.1898	83.61%	180,083,840	76
MRM	MEDIROM Healthcare Technologies Inc	0.6590	0.2890	78.11%	54,040,877	17
OSRH	OSR Holdings Inc	2.47	1.00	68.03%	89,708,175	13
TIVC	Tivic Health Systems Inc	4.82	1.57	48.31%	34,853,397	603
TCRT	Alaunos Therapeutics Inc	4.13	1.33	47.50%	6,345,319	1,241
APVO	Aptevo Therapeutics Inc	2.03	0.6499	47.09%	76,891,822	312
GNPX	Genprex Inc	0.4251	0.1301	44.10%	63,189,372	4,075
NTHI	NeOne Technologies Holdings Inc	9.40	2.40	34.29%	110,069	3

Ticker	Board Name	Price	Change %	Posts (24h)
FNMA	Fannie Mae-No Politics	6.12	-6.85%	95
TWOH	Two Hands Corp	0.0025	+47.06%	376
ELTP	Elite Pharmaceuticals Inc	0.3630	-10.09%	172
AVXL	Anavex Life Sciences Corp	8.25	-3.62%	72
NB	Niocorp Developments Ltd	2.09	+2.96%	14
TGLO	TheGlobe.com Inc	0.3125	-21.86%	20

	Board Name	Posts (24h)
	ORIONS Money Stocks	107
	BBs Stock Haven	99
	DD Support Board and Research Team	66
4	Savvy Trades and Investments	14
5	Rigs Platinum Stock Alerts	52
6	MOMOS BREAKOUT BOARD	60

Ticker	Name	Price	Change %	Market Cap	Volume ($)
BTC	Bitcoin	82,514.35	0.05%	1,639.5B	6.4B	Message Board Quote News
ETH	Ethereum	1,804.12	0.58%	218.5B	2.4B	Message Board Quote News
USDT	Tether USD	0.99962	-0.02%	141.9B	448.1M	Message Board Quote News
XRP	Ripple	2.05	1.49%	119.0B	1.6B	Message Board Quote News
BNB	Binance Coin	589.75	-0.01%	93.5B	388.0M	Message Board Quote News
SOL	Solana	116.31	-0.88%	57.2B	1.7B	Message Board Quote News
USDC	USD Coin	0.9998	-0.02%	56.1B	1.6B	Quote News
DOGE	Dogecoin	0.16017	-2.07%	23.8B	432.8M	Message Board Quote News
ADA	Cardano	0.6456	0.97%	23.3B	231.3M	Message Board Quote News
TRX	TRON	0.237996	1.80%	20.5B	135.0M	Message Board Quote News

Play Episode

8min

Proactive - Interviews for investors

Sintana Energy advances Orange Basin portfolio with key exploration updates

Sintana Energy CEO Robert Bose recently spoke with Steve Darling from Proactive to provide a comprehensive update on the company’s Orange Basin assets, highlighting significant progress across PEL 83, PEL 90, PEL 87, and PEL 82. Bose sahred positive results from the Mopane 3-X well on PEL 83, operated by Galp. The well, which targeted new AVO anomalies 10 and 13, delivered better-than-expected results across nearly every parameter, confirming the presence of high-quality oil and condensate. This discovery has the potential to establish a new development hub, positioning PEL 83 as a key asset in the basin. Moving forward, activity will focus on evaluating partnership opportunities, with Galp expected to seek new partners in the coming quarters. The first Chevron-operated well on PEL 90 did not encounter commercial hydrocarbons but was still regarded as a technical success. Bose emphasized the company’s confidence in the exploration potential of the block, noting that the joint venture partners plan to return for further drilling later this year. Bose also provided an update on PEL 87’s Saturn Superfan prospect, where Woodside Energy chose not to proceed after completing a 3D seismic survey. Despite this, Sintana remains highly optimistic and is now in discussions with alternative supermajor partners. “We’re very excited about opening up the doors to larger, potential partners,” Bose stated, highlighting the continued confidence in the asset’s potential. Chevron has officially completed its farm-in at PEL 82, located in the Walvis Basin, paving the way for drilling operations next year. Bose also pointed to the growing political support for oil and gas development in Namibia, with upstream regulatory oversight now moved directly under the President’s office—a move he called “a huge step forward” for the industry. This shift reinforces the government’s commitment to fostering a thriving energy sector that could significantly contribute to national GDP growth. #pro

Proactive - Interviews for investors

Acusensus talks global expansion and growth drivers

Acusensus Ltd Managing Director talked with Proactive at AIM's Small and Midcap Conference about the company’s progress in road safety technology, its global expansion, and the upcoming launch of a new product line aimed at road worker protection. Alex Jannink, Managing Director and Co-founder of Acusensus, explained how the company pioneered enforcement cameras targeting behaviours like mobile phone use and seatbelt compliance. “We supply these automated enforcement cameras...and we receive a fixed monthly fee essentially for those services,” he said, outlining the company's outsourced business model under long-term government contracts. While 93% of revenues currently come from Australia, Jannink confirmed growth is underway internationally, with active customers in the United States and United Kingdom. Acusensus has also secured a nationwide speed enforcement contract in New Zealand, expected to contribute significantly from the next financial year. Jannink highlighted the broader social mission behind the business: “The whole goal of the company is to change behaviours and to save lives.” He pointed to strong behavioural impacts from previous deployments, including a six-fold drop in mobile phone use and a 21% reduction in road fatalities in New South Wales. A new road worker safety product line is also in development and, according to Jannink, “can be as large as the enforcement business.” #Acusensus #RoadSafety #AItechnology #TrafficEnforcement #DriverSafety #ASXStocks #GovernmentContracts #InfrastructureSafety #SmartCameras #RoadWorkerProtection #AutonomousTech #InvestSmart #PublicSafetyTech

Proactive - Interviews for investors

Genflow Biosciences CEO welcomes new investment; outlines dog longevity trial

Genflow Biosciences PLC CEO Dr Eric Leire talked with Proactive's Stephen Gunnion about a pivotal new direction for the company as it initiates a clinical trial focused on improving aging in dogs. Leire described the trial as a natural evolution from Genflow's previous success in mice, noting the commercial appeal of the canine market. “There is nothing to improve really the quality of life of our aging dogs,” he said, adding that the study meets a significant unmet need. The trial will run for one year, with six months of treatment followed by six months of assessment. It's being managed by independent contract research organisation Syngene. Leire emphasised the scientific rigour of the trial, which is controlled, randomised and includes both aesthetic and biological endpoints. These include coat quality, mitochondrial function, and methylation clocks — all of which have potential crossover value for human applications. Leire also highlighted the company’s differentiated approach compared to US competitors using repurposed drugs like metformin. Genflow, he said, is pursuing gene therapy with the potential for greater impact. The investment supporting the trial, although limited in size, is seen as a strategic vote of confidence, bringing in credible investors from outside the UK, including the US. Leire described the initiative as a major step that could generate near-term revenue and redefine the company’s biotech positioning. For more company updates, visit Proactive's YouTube channel. Don’t forget to like the video, subscribe to the channel, and hit the notification bell for future content. #GenflowBiosciences #GeneTherapy #DogAging #BiotechInvestment #LongevityResearch #Mitochondria #PetHealth #ClinicalTrials #AgingDogs #BiotechNews

Proactive - Interviews for investors

Southern Cross Gold reveals Sunday Creek scale

Southern Cross Gold Consolidated CEO Michael Hudson talked with Proactive at the AIM's Small and Midcap Conference about the company’s focus on gold and antimony exploration in Victoria, Australia, particularly at the Sundae Creek project. Hudson outlined the scale and significance of the discovery, describing it as “one of the most exciting gold discoveries globally… a rare tier one multi-million ounce high grade discovery.” The company is advancing exploration rapidly, with six drill rigs currently operating and plans to expand to eight. Hudson said the company has completed around 70km of drilling and estimates an exploration target of 2.2 to 3.2 million ounces gold equivalent, grading between 8.5 to 10.6 grams per tonne – all within just 5% of the identified trend. Antimony also plays a key role. Hudson explained that China and Russia dominate the global market and recent export bans have highlighted supply vulnerabilities: “You don't have a defense industry without it. And the Western world really doesn't have it. We've got it.” Hudson also reflected on the company’s recent inclusion in the All Ordinaries Index, following the merger of Canadian and Australian entities. He said it marks the first index entry for Southern Cross Gold Consolidated and is “a reflection on a business that's less than three years old.” #SouthernCrossGold #SundayCreek #GoldExploration #Antimony #ASX #MiningStocks #JuniorMiners #ResourceInvesting #MichaelHudson #AllOrdinaries #GoldAndAntimony #AustralianMining

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Join the InvestorsHub Community

Trump’s Tariff Announcement Triggers Nosedive On Wall Street

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Join the InvestorsHub Community

Trump’s Tariff Announcement Triggers Nosedive On Wall Street

Go Ad-Free